Browse by author
Lookup NU author(s): Dr Ian HardcastleORCiD,
Dr Christine Arris,
Dr Johanne Bentley,
Professor Nicola CurtinORCiD,
Professor Jane Endicott,
Dr Ashleigh Gibson,
Emeritus Professor Bernard Golding,
Professor Roger Griffin,
Dr Veronique Mesguiche,
Professor Herbie Newell,
Professor Martin NobleORCiD,
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
The adenosine 5′-triphosphate (ATP) competitive cyclin-dependent kinase inhibitor O6-cyclohexylmethylguanine (NU2058, 1) has been employed as the lead in a structure-based drug discovery program resulting in the discovery of the potent CDK1 and -2 inhibitor NU6102 (3, IC50 = 9.5 nM and 5.4 nM vs CDK1/cyclinB and CDK2/cyclinA3, respectively). The SAR for this series have been explored further by the synthesis and evaluation of 45 N2-substituted analogues of NU2058. These studies have confirmed the requirement for the hydrogen bonding N2-NH group and the requirement for an aromatic N2-substituent to confer potency in the series. Additional potency is conferred by the presence of a group capable of donating a hydrogen bond at the 4′-position, for example, the 4′-hydroxy derivative (25, IC50 = 94 nM and 69 nM vs CDK1/cyclinB and CDK2/cyclinA3, respectively), 4′-monomethylsulfonamide derivative (28, IC50 = 9 nM and 7.0 nM vs CDK1/cyclinB and CDK2/cyclinA3, respectively), and 4′-carboxamide derivative (34, IC50 = 67 nM and 64 nM vs CDK1/cyclinB and CDK2/cyclinA3, respectively). X-ray crystal structures have been obtained for key compounds and have been used to explain the observed trends in activity.
Author(s): Hardcastle IR, Arris CE, Bentley J, Boyle FT, Chen Y, Curtin NJ, Endicott JA, Gibson AE, Golding BT, Griffin RJ, Jewsbury, P., Menyerol, J., Mesguiche, V., Newell, D.R., Noble, M., Pratt, D., Wang, L., Whitfield, H.J.
Publication type: Article
Publication status: Published
Journal: Journal of Medicinal Chemistry
Print publication date: 01/07/2004
ISSN (print): 0022-2623
ISSN (electronic): 1520-4804
PubMed id: 15239650
Altmetrics provided by Altmetric